Drug Type Small molecule drug |
Synonyms |
Target |
Action antagonists |
Mechanism LTB4R antagonists(Leukotriene B4 receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC25H31N3O3S |
InChIKeyJDXVNCOKDAGOAM-UHFFFAOYSA-N |
CAS Registry491577-61-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Osteoporosis | Phase 1 | - | - | |
Osteoporosis | Phase 1 | - | - | |
Osteoporosis | Phase 1 | South Korea | - |